Pfizer celebrates UK Viagra switch
This article was originally published in OTC Bulletin & The Rose Sheet
Men in the UK will soon have OTC access to Pfizer’s blockbuster erectiledysfunction treatment Viagra after an application to switch the sildenafil-based product was given the green light.
You may also be interested in...
OTC Marketing Awards 2019 Winners Announced – GSK Crowned Company Of The Year, Pfizer’s Viagra Takes Best Brand
GSK, Pfizer, HRA Pharma and Mentholatum all enjoyed a particularly fruitful evening at the OTC Marketing Awards 2019. J&J, P&G and RB were also among the winners at a celebration of the best and brightest in the UK consumer health market.
Just three years after its founding, Chinese cell therapy developer IASO Bio already has two assets in clinical development and the Nanjing firm has recently attracted $60m in financing. In an exclusive interview, its R&D head told Scrip that speed and partnerships are propelling Chinese developers on a trajectory to quickly catch up with the west in the emerging cell-therapy arena.
Updated guidance from England’s National Institute for Health and Care Excellence says two neurostimulation systems for treatment-resistant depression and epilepsy should only be used under special conditions. See what LivaNova’s VP of difficult-to-treat depression, Jonathan Walker, said about it here.